Money20/20 Unveils Global Powerhouse Jury for Inaugural Money Awards
21.5.2025 13:48:00 CEST | Business Wire | Press Release
Money20/20, the world's leading fintech show, and the place where money does business, today announced its inaugural jury for The Money Awards, featuring an unprecedented assembly of distinguished leaders from across the global financial technology ecosystem from traditional banks, fintechs, neobanks, venture capitalists, and the world’s most influential brands. The jury represents in-depth knowledge and expertise from around the world spanning North America, Europe, Latin America, Asia, Middle-East and Africa, reinforcing the awards' position as the definitive global benchmark for fintech excellence.
The jury lineup for the Money Awards are:
Banking Award
Jury President:
Joanne Hannaford, Chief Information Officer & Chief Product Officer Corporate Bank, Deutsche Bank
Jury Members:
Annerie Vreugdenhil, Chief Commercial Officer Personal & Business Banking, ABN AMRO N.V.
Elizabeth Jimenez, Senior Vice President, Strategic Risk, Citi
Glauber Mota, CEO, Revolut
John Piazza, Head of Product, Newline by Fifth Third
Lukasz Strozek, Chief Technology Officer, LendingClub
Nobutake Suzuki, President & CEO, MUFG Innovation Partners Co., Ltd.
Tosin Eniolorunda, Founder & Group CEO, Moniepoint Inc.
Diamond Award
Jury President:
Lynn Martin, President, NYSE Group
Jury Members:
Manolo Sánchez, CEO, Adelante Ventures LLC
Nico Kersten, CEO & Managing Director, Mercedes pay GmbH
Suzan Kereere, President, Global Markets, PayPal
Tim Shen, CEO, LianLian Global
Payments Award
Jury President:
Howard R. Fields, Chief Ethics & Compliance Officer, Mastercard
Jury Members:
Brigette Korney, Global Head of Risk, Adyen
Camilla Bullock, CEO, Emerging Payments Association Asia
Meron Colbeci, Chief Product Officer, Checkout.com
Neetika Bansal, Head of Money Management & Crypto, Stripe
Olugbenga Agboola, Founder & CEO, Flutterwave Inc.
Pebbles Sy, Chief Technology & Operations Officer, GCash
Prajit Nanu, CEO, Nium
Theresa Gongora, Executive Vice President, Merchant Solutions, Global Payments, Inc.
Partnerships & Strategic Alliance Award
Jury President:
Anthony Thomas, Managing Director, FinTech, Delivery Hero
Jury Members:
Jose Antonio Murillo, CEO, RappiCard
Joyce Lim, Director of Global Payments, Expedia Group
Mariette Ferreira, Chief Marketing Officer, PPRO
Mohammed Alzubi, Founder & Managing Partner, Nama Ventures
Ranjit Sarai, VP Digital & Ecosystem, Canada, Western Union
Sarah Kocianski, CEO, FinTech Wales
Suvo Sarkar, Host, Money Majlis podcast, Founder & CEO, 3D Advisory
Startup Award
Jury President:
Chetan Puttagunta, General Partner, Benchmark
Jury Members:
Annie Guo, CEO, Silkpay
Mareme Dieng, Partner, 500 Global
Mariel Vasquez, Head of Innovation & Growth, HSBC Mexico
Mark Fiorentino, Partner, Bain Capital Ventures
Noam Inbar, Partner, Viola Fintech
Steph Choo, General Partner, Portage
Vicky Bindra, CEO, Trulioo
Vishnu Acharya, Head of Strategy, M&A, Investments, Razorpay
"The Money Awards Jury plays a vital role in setting the global benchmark for recognizing transformative innovation across the fintech ecosystem.The caliber and diversity of our jury panel reflects the truly global nature of financial innovation," said Grania Chesterton, Vice President of Awards at Money20/20. "By bringing together voices from established financial capitals and emerging fintech hubs, we're ensuring that The Money Awards recognize excellence that transcends geographical boundaries and represents the future of finance on a truly global scale."
Jurors will evaluate submissions through a transparent and impartial process that includes online reviews followed by in-person deliberations at Money20/20 USA. The winners will be announced live at Money20/20 USA in Las Vegas in October, ensuring global recognition.
Winners will receive a bespoke trophy and benefit from year-round visibility through Money20/20’s platforms, including exclusive speaking opportunities, media exposure, investor visibility, and networking at Money20/20 shows worldwide. Entries are open now and are live until the 29th of July.
For more information about The Money Awards, visit www.money2020.com/award.
About Money20/20
Launched by industry insiders in 2012, Money20/20 has rapidly become the heartbeat of the global fintech ecosystem. Over the last decade, the most innovative, fast-moving ideas and companies have driven their growth on our platform. Mastercard, Wise, J.P. Morgan, SHIELD, Convera, Stripe, Google, VISA, Adyen, and more make transformational deals and raise their global profile with us. Money20/20 attracts leaders from the world’s greatest banks, payments companies, VC firms, regulators and media platforms: convening to cut industry-shaping deals, build world-changing partnerships and unlock future-defining opportunities in Bangkok (22-24 April 2025) in Amsterdam (3-5 June 2025), in Riyadh ( 15-17 September 2025), and in Las Vegas (26-29 October 2025). Money20/20 is where the world’s fintech leaders convene to grow their businesses. Money20/20 is part of Informa Festivals. Follow Money20/20 on X and LinkedIn for show developments and updates. We’re Where Money Does Business. Follow Money20/20 on X for show developments and updates. You can also find us on LinkedIn at Money20/20.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250521771868/en/
Contacts
For more information, please contact:
Tina Loncaric
Global Head of PR
Money20/20
tina@money2020.com
M: +1 469 288 5556
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom